Holen Sie sich die Stockscreener-App
3.89
1.57%
0.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FBIO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.83
Offen:
$3.81
24-Stunden-Volumen:
734.25K
Relative Volume:
1.41
Marktkapitalisierung:
$115.75M
Einnahmen:
$80.97M
Nettoeinkommen (Verlust:
$-78.31M
KGV:
-0.3509
EPS:
-11.0849
Netto-Cashflow:
$-129.56M
1W Leistung:
+4.85%
1M Leistung:
+93.53%
6M Leistung:
+124.86%
1J Leistung:
+112.57%
1-Tages-Spanne:
$3.72
$3.97
1-Wochen-Bereich:
$3.26
$3.97
52-Wochen-Spanne:
$1.325
$3.97
Fortress Biotech Inc Stock (FBIO) Company Profile
Firmenname
Fortress Biotech Inc
Sektor
Branche
Telefon
781-652-4500
Adresse
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Vergleichen Sie FBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
3.89 | 114.85M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-15 | Fortgesetzt | ROTH MKM | Buy |
| 2022-08-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-02 | Eingeleitet | The Benchmark Company | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2018-02-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-03-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-10-03 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten
Fortress Biotech Inc. stock outlook for YEAREarnings Risk Report & AI Driven Stock Reports - Newser
Heatmap analysis for Fortress Biotech Inc. and competitorsPortfolio Update Summary & Smart Investment Allocation Insights - Newser
Is this a good reentry point in Fortress Biotech Inc.2025 Market Sentiment & Daily Profit Focused Screening - Newser
What machine learning models say about Fortress Biotech Inc.Portfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Tools to assess Fortress Biotech Inc.’s risk profile2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Fortress Biotech (NASDAQ:FBIO) Share Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Volume spikes in Fortress Biotech Inc. stock – what they meanJuly 2025 Movers & Community Verified Swing Trade Signals - Newser
What Fibonacci levels say about Fortress Biotech Inc. reboundM&A Rumor & Weekly High Conviction Ideas - Newser
Has Fortress Biotech Inc. formed a bullish divergenceJuly 2025 Reactions & High Conviction Investment Ideas - Newser
Applying big data sentiment scoring on Fortress Biotech Inc.Weekly Profit Report & Daily Stock Momentum Reports - Newser
Fortress Biotech Inc. stock prediction for this weekMarket Movement Recap & Expert Approved Momentum Ideas - Newser
what fibonacci levels say about fortress biotech inc. reboundDay Trade & Free Verified High Yield Trade Plans - Newser
How to monitor Fortress Biotech Inc. with trend dashboardsJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
Is Fortress Biotech Inc. showing signs of accumulationDividend Hike & Weekly Momentum Picks - Newser
Does Fortress Biotech Inc. fit your quant trading modelEarnings Trend Report & Growth Focused Stock Reports - Newser
Visualizing Fortress Biotech Inc. stock with heatmaps2025 Earnings Surprises & Real-Time Volume Trigger Notifications - Newser
How to manage a losing position in Fortress Biotech Inc.Weekly Volume Report & Safe Entry Point Alerts - Newser
Is Fortress Biotech Inc. building a consolidation baseJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - Newser
Will Fortress Biotech Inc. benefit from macro trendsRisk Management & Verified Technical Signals - Newser
Fortress Biotech, Inc. (NASDAQ:FBIO) Soars 28% But It's A Story Of Risk Vs Reward - 富途牛牛
Is it too late to sell Fortress Biotech Inc.Earnings Recap Report & Low Risk Entry Point Tips - Newser
Using portfolio simulators with Fortress Biotech Inc. included2025 Top Gainers & Community Verified Trade Signals - Newser
Volatility clustering patterns for Fortress Biotech Inc.Watch List & Growth Focused Entry Point Reports - Newser
Fortress Biotech Inc. stock daily chart insightsJuly 2025 Setups & High Yield Equity Trading Tips - Newser
Can Fortress Biotech Inc. hit a new high this monthMarket Trend Review & Safe Capital Preservation Plans - Newser
Using Ichimoku Cloud for Fortress Biotech Inc. technicalsJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Short interest data insights for Fortress Biotech Inc.2025 Retail Activity & Safe Capital Growth Tips - Newser
Will Fortress Biotech Inc. price bounce be sustainableMarket Activity Report & Daily Oversold Bounce Ideas - Newser
Fortress Biotech Inc.’s volatility index tracking explained2025 Price Action Summary & AI Driven Price Predictions - Newser
Fortress Biotech Inc. stock volume spike explained2025 Market Sentiment & Free Community Supported Trade Ideas - Newser
Can you recover from losses in Fortress Biotech Inc.2025 Top Decliners & Verified Stock Trade Ideas - Newser
Real time scanner hits for Fortress Biotech Inc. explainedJobs Report & Community Verified Watchlist Alerts - Newser
Detecting support and resistance levels for Fortress Biotech Inc.Market Growth Summary & Verified Entry Point Signals - Newser
Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fortress Biotech Inc-Aktie (FBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN |
Sep 23 '24 |
Buy |
1.84 |
763,359 |
1,404,581 |
3,657,264 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):